| Line Item | 2026-01-02 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $209.6M | — | +4.9% |
| Cost of Revenue | $139.8M | — | +6.5% |
| Gross Profit | $69.8M | — | +1.9% |
| R&D Expense | $21.7M | — | -7.7% |
| SG&A Expense | $32.7M | — | -3.3% |
| Operating Income | $15.4M | — | +37.5% |
| Pre-tax Income | $3.8M | — | +52.0% |
| Income Tax | $1.4M | — | -46.2% |
| Net Income | $2.3M | — | +866.7% |
| EPS (Basic) | $0.06 | — | +700.0% |
| EPS (Diluted) | $0.05 | — | +600.0% |
| Line Item | 2026-01-02 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $119.5M | -17.6% | -32.1% |
| Short-term Investments | $6.1M | -39.6% | -83.3% |
| Accounts Receivable | $146.5M | -6.4% | +6.1% |
| Inventory | $328.0M | +9.6% | +17.2% |
| Current Assets | $633.6M | -1.3% | -3.5% |
| Total Assets | $1.10B |
| Line Item | 2026-01-02 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$16.1M | — | -269.5% |
| Capital Expenditures | $10.7M | — | +154.8% |
| Investing Cash Flow | -$7.7M | — | -156.7% |
| Financing Cash Flow | -$1.6M | — | -101.3% |
| Free Cash Flow | -$26.8M | — | -605.7% |
| -17.6% |
| Current Liabilities | $163.0M | -12.9% | +8.3% |
| Long-term Debt | $367.6M | +0.0% | -35.2% |
| Total Liabilities | $607.2M | -2.2% | -22.0% |
| Stockholders' Equity | $476.9M | +0.9% | -11.7% |